Related by context. All words. (Click for frequent words.) 71 colorectal polyps 70 adenomas 69 pre cancerous polyps 69 adenoma 68 colon tumors 68 pre cancerous growths 67 precancerous polyps 67 intestinal polyps 66 polyps 65 colorectal adenomas 65 benign breast 64 benign polyps 64 advanced adenomas 64 colon polyp 64 benign growths 64 esophageal adenocarcinoma 63 endometrial hyperplasia 63 colorectal tumors 63 adenomatous polyps 63 precancerous polyp 63 precancerous lesions 62 cancerous colon polyps 62 polyps growths 62 polyp 62 precancerous growths 62 uterine cancers 62 colorectal adenoma 62 precancerous colon polyps 62 endometrial cancers 61 colorectal polyp 61 premenopausal breast cancer 61 lobular breast cancer 61 malignant polyps 60 nonmelanoma skin cancers 60 gallstone disease 60 familial adenomatous polyposis 60 pituitary tumors 60 prostate cancers 60 cancerous polyps 60 colorectal cancer 60 mammary tumors 60 bowel polyps 60 elevated CRP 60 breast endometrial 60 bowel cancers 60 endometrial cancer 60 breast cancer recurrence 60 NP CRNs 60 polyp recurrence 60 precancerous tumors 60 breast tumors 60 Colon polyps 59 untreated celiac disease 59 abnormal growths 59 prostate tumor 59 colorectal neoplasms 59 Polyps 59 testosterone supplementation 59 artery blockages 59 tumors 59 colorectal neoplasia 59 ductal cancer 59 basal cell nevus syndrome 59 atherosclerotic lesions 59 atypical hyperplasia 59 mammary cancers 59 advanced adenoma 59 atypical ductal hyperplasia 59 intravenous bisphosphonates 59 ADPKD 59 colonic polyps 58 gamma tocopherol 58 urate levels 58 bladder cancers 58 PSA velocity 58 adiponectin levels 58 cervical lesions 58 heart disease 58 prostate tumors 58 malignant growths 58 hereditary predisposition 58 statin medications 58 intensive statin therapy 58 lipid lowering medications 58 Barrett esophagus 58 invasive breast cancer 58 pre cancerous cells 58 microbleeds 58 pre cancerous lesions 58 lobular carcinoma 58 urate 58 precancerous condition 57 keloid 57 coronary disease 57 basal cell carcinomas 57 amino acid homocysteine 57 nonalcoholic steatohepatitis 57 atypia 57 postmenopausal breast cancer 57 dietary fat 57 proliferative diabetic retinopathy 57 colon cancer 57 benign proliferative breast 57 bisphosphonate drugs 57 tibolone 57 atherosclerotic disease 57 adenomatous 57 narcolepsy cataplexy 57 Malignant tumors 57 DCIS lesions 57 BRCA1 mutations 57 artery clogging plaque 57 colon adenomas 57 glandular tissue 57 HNSCC 57 thrombotic events 57 oophorectomy 57 fatty plaque 57 GnRH agonists 57 estrogen receptor negative 56 colorectal carcinoma 56 ovarian hormones 56 endometrial kidney 56 leiomyomas 56 osteosarcomas 56 anaplastic 56 serum PSA 56 nonmelanoma skin cancer 56 colon cancers 56 serum calcium levels 56 premenopausal 56 metachronous 56 subclinical hyperthyroidism 56 lobular cancer 56 prostate tissue 56 BRCA mutations 56 statins 56 LDLs 56 grade gliomas 56 uric acid levels 56 folate intake 56 non aspirin NSAIDs 56 endogenous estrogen 56 thyroid tumors 56 breast cancers 56 cancerous breast 56 arterial plaque 56 carotid atherosclerosis 56 adenocarcinomas 56 brain shrinkage 56 carotid plaque 56 undergoing radical prostatectomy 56 CMV infection 56 atherosclerotic plaques 56 precursor lesions 56 homocysteine levels 56 squamous cell cancers 56 malignancy 56 NAFLD 56 BRCA2 mutations 56 Cholangiocarcinoma 56 recurrent VTE 56 fibroadenomas 56 transthyretin 56 keloids 56 Darapladib 56 parathyroid 56 noncancerous tumors 56 Prostate Specific Antigen PSA 56 incidentalomas 56 amyloid deposition 55 micrometastases 55 squamous cell lung cancer 55 parathyroid glands 55 microvascular disease 55 primary ovarian insufficiency 55 bladder tumors 55 BRCA mutation 55 lung tumors 55 bone metastasis 55 hormone therapy estrogen 55 preterm delivery 55 polycystic ovarian syndrome PCOS 55 diverticula 55 esophageal cancers 55 PSADT 55 basal cell cancers 55 acne lesions 55 prostate cancer 55 thyroid nodules 55 pre cancerous lesion 55 endometrial carcinoma 55 benign polyp 55 anticoagulants blood thinners 55 estrogen progestin combination 55 thromboembolic disease 55 gallstone formation 55 postmenopausal hormone therapy 55 testicular cancers 55 rectal cancers 55 melanoma tumors 55 atypical moles 55 grade glioma 55 cancerous tumors 55 Hashimoto thyroiditis 55 grade dysplasia 55 colorectal cancers 55 GISTs 55 dutasteride 55 noncancerous 55 unresectable tumors 55 invasive ductal 55 basal cell skin 55 reflux disease 55 subclinical hypothyroidism 55 premalignant 55 selenium supplementation 55 painkiller ibuprofen 55 estrogen therapy 55 beta catenin protein 55 cancerous lesions 55 thromboembolic events 55 calcified plaque 55 cruciferous vegetables 55 malignant melanomas 55 elevated triglycerides 55 prostate specific 55 inflammatory polyarthritis 55 adrenal tumors 55 endometriosis ovarian cysts 55 necrotic core 55 colon rectal 55 improves insulin sensitivity 55 gallstones 55 poorer prognosis 55 arterial calcification 55 estrogen progestin therapy 55 brain lesions 55 molecular abnormalities 55 Barrett Esophagus 55 chemopreventive agent 55 digestive tract cancers 55 statin 55 adenoma recurrence 55 antigen PSA 55 male hormones androgens 55 pre cancerous 55 tumor recurrence 55 endometrial tumors 55 coronary blockages 55 fatal arrhythmias 55 metastatic tumors 55 progestins 54 metastatic lesions 54 precancerous tissue 54 folic acid intake 54 lipid abnormalities 54 hormonally sensitive 54 venous thromboembolism 54 carotid artery blockage 54 anal lesions 54 Estrogens 54 premenstrual syndrome PMS 54 cervical precancers 54 neural tube birth defects 54 familial pancreatic cancer 54 Rectal cancer 54 slow metabolizers 54 bariatric surgeries performed 54 disease NAFLD 54 asymptomatic carotid stenosis 54 polycystic ovary syndrome PCOS 54 elevated triglyceride levels 54 endocrine tumors 54 leukoplakia 54 dose aspirin 54 PGDH 54 Basal cell 54 detect polyps 54 atypical fractures 54 adrenal function 54 coronary artery disease 54 nonalcoholic steatohepatitis NASH 54 surgical biopsies 54 precancerous 54 coronary calcification 54 Statin therapy 54 prostate cancer PCa 54 statins cholesterol lowering 54 fructose intake 54 alpha carotene 54 hydroxychloroquine 54 precancerous cervical 54 plaque buildup 54 differentiated thyroid 54 LDL cholesterol 54 ovarian tumors 54 squamous cell carcinomas 54 catheter angiography 54 autoantibodies 54 uterine tumors 54 selenium supplements 54 ductal breast cancer 54 gastrointestinal stromal tumor 54 Barrett esophagus BE 54 serum uric acid 54 thrombotic complications 54 fibrocystic disease 54 selective NSAIDs 54 diverticulosis 54 LDL cholesterol levels 54 recurrent UTIs 54 Hydroxyurea 54 periodontal infections 54 colon breast 54 hyperkalemia 54 prostate glands 54 cardiovascular disease 54 prostate abnormalities 54 salsalate 54 fetuin 54 potentially cancerous polyps 54 transferrin saturation 54 screening colonoscopies 54 soy isoflavones 54 venous blood clots 54 distant metastases 54 Celebrex celecoxib 54 coronary artery calcium 54 precancer 54 Wernicke encephalopathy 54 abdominal adiposity 54 prostate specific antigen 54 BRCA2 gene mutation 54 raloxifene Evista 54 RBP4 54 fatty plaques 54 atherosclerosis narrowing 54 GRK5 54 glucose intolerance 54 amyloid deposits 54 carcinoid tumor 54 breast cancer metastasis 54 PCa 54 metabolic abnormality 54 ductal carcinomas 54 androgen deprivation 54 TP# mutation 54 renal cell carcinomas 54 cancers 54 cerebral microbleeds 54 remove precancerous growths 54 carotid stenosis 54 obese postmenopausal 54 melanomas 54 osteopontin 54 pancreatic tumor 54 glycemic diet 54 clots 54 tau proteins 54 gestational diabetes mellitus 54 EXJADE 54 corticosteroid therapy 54 atopic disease 54 prostate gland 54 lymph node biopsies 54 haemorrhagic stroke 54 serous ovarian cancer 54 arterial plaques 53 ABCB1 53 N telopeptide 53 H. pylori eradication 53 premalignant lesions 53 fibrate drugs 53 recurrent UTI 53 SERMs 53 clinically insignificant 53 hyperplastic polyps 53 acoustic neuromas 53 fibrin deposition 53 colorectal cancer CRC 53 Adenomas 53 macrovascular 53 calcium supplementation 53 bisphosphonate 53 cancerous lumps 53 periodontitis 53 B7 H3 53 metastatic prostate cancer 53 underactive thyroid gland 53 lung adenocarcinoma 53 APOL1 53 prolonged QT interval 53 Colorectal cancers 53 kidney dysfunction 53 NKX2 53 testicular germ cell 53 curable cancers 53 dysglycemia 53 endometrial lining 53 liver metastasis 53 diverticular bleeding 53 upper gastrointestinal bleeding 53 thiazide diuretics 53 fermentable carbohydrates 53 Statin drugs 53 adenomatous polyp 53 blood clots 53 noncancerous tumor 53 cancerdefine 53 invasive ductal breast cancer 53 Hormone pills 53 bone thinning 53 ovarian cancers 53 ovulatory cycles 53 transaminase levels 53 neoplasia PIN 53 ovarian cysts 53 medullary thyroid cancer 53 thyroid hormone levels 53 distal colon cancer 53 lipoma 53 bilateral oophorectomy 53 testicular tumors 53 inherited predisposition 53 abdominally obese 53 cataract formation 53 colonoscopy screenings 53 pulmonary metastases 53 precancerous lesion 53 liver scarring 53 cancerous polyp 53 oesophageal adenocarcinoma 53 microalbuminuria 53 endometrial 53 lipomas 53 androgen suppression therapy 53 metastatic prostate 53 hardened arteries 53 lung metastasis 53 Fatty Liver Disease 53 AAT deficiency 53 calcium oxalate stones 53 ACAT2 53 menopausal hormone therapy 53 cholesterol lowering medication 53 squamous cell 53 melanoma 53 oral bisphosphonate 53 spine fractures 53 dysplastic nevi 53 trans palmitoleic acid 53 sarcosine 53 squamous cell skin 53 atherosclerosis 53 fibroids 53 nondiabetics 53 cancerous growths 53 mitochondrial mutations 53 Premenopausal women 53 renal toxicity 53 cartilage degeneration 53 gastric adenocarcinoma 53 hormonally responsive 53 adiponectin 53 HGPIN 53 breast lumps 53 Stomach cancer 53 colorectal liver metastases 53 lichen planus 53 anti androgen 53 precancerous spots 53 prostate adenocarcinoma 53 KCNH2 53 hormone deprivation 53 basal cell carcinoma 53 LRP5 53 lowering LDL cholesterol 53 arterial blockages 53 elevated homocysteine 53 amyloid plaque 53 LDL cholesterol concentrations 53 c reactive protein 53 serum calcium 53 herpes infection 53 Carcinoid tumors 53 anticlotting drugs 53 venous thromboembolic events 53 ticlopidine 53 postmenopausal hormone 53 Ovary removal 53 elevated LDL cholesterol 53 subclinical atherosclerosis 53 CVD mortality 53 tumor 53 gynecomastia 53 bad cholesterol LDL 53 dexrazoxane 53 chlamydial infection 53 familial hypercholesterolemia 53 chemoprevention 53 RAS mutations 53 glitazones 53 HbF 53 fasting glucose levels 53 arterial thickening 53 genes BRCA1 53 ovarian pancreatic 53 fatty acid oxidation 53 hormone therapy HT 53 plasma homocysteine levels 53 pravastatin Pravachol 53 periodontal disease 53 specific antigen PSA 53 bone resorption 53 androgen deprivation therapy 53 axillary lymph nodes 53 TNF blockers 53 confounding variables 52 malignant prostate 52 SETDB1 52 bisphosphonates 52 prostate carcinogenesis 52 MGUS 52 Melanomas 52 hemorrhagic strokes 52 BRAF gene 52 calcium oxalate 52 HDL cholesterol 52 abnormal mammograms 52 Epidemiologic studies 52 Chronic pancreatitis 52 undergone radical prostatectomy 52 PTEN protein 52 apigenin 52 hypervascular tumors 52 paricalcitol 52 benign tumors 52 hamartomas 52 angiotensin receptor blockers ARBs 52 adrenocortical cancer 52 estrogen 52 prostate TURP 52 metastases 52 gestational diabetes 52 ventricular tachyarrhythmia 52 gum disease 52 hypermethylation 52 type2 diabetes 52 magnesium intake 52 p# mutations 52 hormone therapy 52 prostate pancreatic 52 arterial inflammation 52 melanoma lesions 52 acute phosphate nephropathy 52 ectasia 52 EBV infection 52 ApoE4 gene 52 obstructive coronary artery 52 Prostatitis 52 polyp detection 52 hs CRP 52 OGG1 52 basal cell 52 hereditary breast cancer 52 HER2 expression 52 precancerous cells 52 deep venous thromboses 52 Breast Cancer Risk 52 retinoids 52 leptin resistance 52 abnormal heartbeats 52 type 1diabetes 52 vertebral fractures 52 systemic scleroderma 52 hepatic steatosis 52 tHcy 52 postoperative delirium 52 albuminuria 52 advanced neoplasia 52 seminomas 52 impair fertility 52 Erythropoietic therapies may 52 ferritin 52 parathyroid gland 52 Aneurysms 52 dose oral contraceptives 52 gastrointestinal cancers 52 Bisphosphonates 52 white matter hyperintensities 52 serum creatinine levels 52 angiosarcoma 52 hormone adiponectin 52 disc degeneration 52 Estrogen therapy 52 hyperparathyroidism 52 obstructive coronary 52 cerebral infarction 52 cryptogenic stroke 52 beta carotene supplements 52 neuroblastoma tumors 52 vertebral fracture 52 thyroid stimulating hormone 52 H. pylori infection 52 oxidized LDL 52 anal cancers 52 denser breasts 52 chronic prostatitis 52 MetAP2 52 flutamide 52 breast tissue 52 postoperative mortality 52 breast lesions 52 amyloid proteins 52 cranial radiation 52 prostate cancer CaP 52 chromosomal anomalies 52 guggul 52 intractable epilepsy 52 atherosclerotic plaque 52 carcinoid tumors 52 beta carotene supplementation 52 de ath 52 varicocele 52 PR interval prolongation 52 calcified plaques 52 NAT2 52 arterial blockage 52 lipid lowering therapy 52 serum phosphate 52 Cysts 52 carotid plaques 52 precocious puberty 52 nodal metastasis 52 Squamous cell 52 metabolic abnormalities 52 GSTM1 52 SHBG levels 52 osteopenic 52 acid secretion 52 GBA mutations 52 hsCRP levels 52 breast uterine 52 transfusion syndrome 52 antioxidant nutrients 52 perioperative complications 52 telomere lengths 52 elevated depressive symptoms 52 thyrotoxicosis 52 Vitamin D supplements 52 prostate 52 PIK3CA 52 neurofibroma 52 hormone receptor negative 52 thrombi 52 Heavy menstrual bleeding 52 fibrocystic changes 52 lung nodules 52 cystatin C 52 phytoestrogen 52 treat menopausal symptoms 52 superficial bladder cancer 52 postoperative AF 52 varices 52 Calcium supplements 52 carcinoids 52 benign lesions 52 synovial cells 52 LRP6 52 C Reactive Protein 52 postoperative atrial fibrillation 52 GIST tumors 52 TNFa 52 vascular inflammation 52 premalignant lesion 52 suppresses tumor 52 atherothrombotic events 52 inherited mutations 52 Broccoli sprouts 52 benign lesion 52 noncancerous prostate 52 gastric cardia 52 antihypertensive therapy 52 statin drugs 52 pleural mesothelioma 52 oncomodulin 52 PKCi 52 TZDs 52 TGFBR1 * 6A 52 endothelial dysfunction 52 airway constriction 52 glioblastoma tumor 52 Vigorous exercise 52 severe periodontitis 52 β blockers 52 immunosuppressive medications 52 contralateral breast 52 axillary node dissection 52 lung lesions 52 density lipoprotein HDL cholesterol 52 node metastases 52 cardiac hypertrophy 52 glycated hemoglobin levels 52 DFMO 52 breast cancer recurrences 52 leukaemic stem cells 52 metabolic syndrome 52 estrogen metabolites 52 abnormal lipid 52 modifiable risk 52 breast biopsies 52 GSTT1 52 CP CPPS 52 invasive carcinoma 52 persistent pulmonary hypertension 52 induce regression 52 cancerous nodules 52 finasteride Proscar 52 abnormalities 52 undergone hysterectomy 52 nerve degeneration 52 lowering triglyceride levels 52 SHBG 52 colon rectal cancer 52 atrial fibrillation 52 macrovascular disease 51 fibrocystic 51 prophylactic mastectomy 51 precancers 51 distal colon 51 nonvertebral fracture 51 cyclin E 51 malignancies 51 HPV infections 51 BRAF mutation 51 vitamin K1 51 gouty arthritis 51 pancreatic prostate 51 Genetic variants 51 mutated BRCA1 51 erlotinib Tarceva 51 homozygous familial hypercholesterolemia 51 breast carcinoma 51 achalasia 51 cardiovascular mortality 51 dissolve clots 51 arterial stiffening 51 axillary dissection 51 ischemic strokes 51 PCSK9 protein 51 neoplastic lesions 51 microvascular complications 51 Hurthle cell 51 poor metabolizers 51 liver dysfunction 51 SIRT3 51 epigenetic changes 51 breast tenderness 51 Sentinel node biopsy 51 folate supplementation 51 esophageal squamous cell carcinoma 51 Diverticulosis 51 postmenopausal hormone replacement 51 Endometrial cancer 51 epithelial tumors 51 preventive mastectomies 51 XZK 51 macrovascular complications 51 neurodevelopmental outcome 51 motor neuron degeneration 51 aspirin regimen 51 APOE e4 51 subependymal giant cell 51 immunosuppressive medication 51 pelvic lymph nodes 51 COX inhibitors 51 senescent cells 51 fatty liver disease 51 plasma triglycerides 51 myopathy rhabdomyolysis 51 rectal cancer 51 Uterine cancer 51 beta sitosterol 51 meningioma 51 subclinical disease 51 antiplatelet drugs 51 tamoxifen 51 amyloid plaque formation 51 dentinal hypersensitivity 51 ovarian lung 51 fat diets 51 cilostazol 51 NSAIDs 51 prostate cancer metastases 51 clinically detectable 51 statin therapy 51 homocysteine concentrations 51 HIV HCV coinfected 51 Menopausal hormone therapy 51 HBV infection 51 neoplasia 51 abdominal fat 51 goblet cells 51 Squamous cell carcinomas 51 intima media thickness 51 oral antidiabetic medication 51 loop diuretics 51 constipation hemorrhoids 51 pre malignant lesions 51 oropharyngeal cancer 51 phytoestrogens 51 hemorrhagic complications 51 ximelagatran 51 STAT4 51 apolipoprotein E4 51 serum testosterone levels 51 CaM kinase II 51 meningiomas 51 polypoid 51 T1DM 51 Barrett mucosa 51 Adjuvant chemotherapy 51 nonvertebral fractures 51 platelet reactivity 51 ovaries surgically 51 thoracic aortic aneurysm 51 PTEN gene 51 benign nodules 51 PPARγ 51 RBP4 levels 51 pre menopausal 51 irregular menstrual cycles 51 radioiodine therapy 51 urothelial cancer 51 Benign prostatic hyperplasia BPH 51 renal dysfunction 51 malignant transformation 51 synthetic progestin 51 mixed hyperlipidemia 51 uric acid kidney stones 51 prostate breast 51 postoperative pulmonary 51 hyperplastic 51 androgen depletion therapy 51 periodontal infection 51 Leitzmann 51 spontaneous preterm delivery 51 left ventricular hypertrophy 51 troponin T 51 PPAR γ 51 adenoid cystic carcinoma 51 bowel resection 51 pancreatic ovarian 51 glioblastoma tumors 51 beta blocker therapy 51 prognostic indicator 51 prophylactic mastectomies 51 Seewaldt 51 selenium intake 51 thromboembolism 51 insulin sensitizers 51 NSAID naproxen 51 irregular heartbeats 51 prediabetes 51 calculi 51 clefting 51 keloid scarring 51 colorectal 51 recurrent venous thromboembolism 51 underarm lymph nodes 51 pancreatic tumors 51 ovarian endometrial 51 systolic hypertension 51 LQTS 51 calcium excretion 51 plasma selenium 51 anakinra 51 melanoma skin 51 anticlotting 51 hemangiomas 51 precancerous cervical lesions 51 thyrotropin levels 51 Gorlin syndrome 51 lymphatic cancers 51 NMDA receptor antagonists 51 SOD2 gene 51 Severe Primary IGFD 51 malignant brain 51 bisphosphonate therapy 51 cranial irradiation 51 uncontrolled epilepsy 51 ApoA1 51 gastric cancers 51 diabetic rats 51 malignant tumors 51 serum GGT 51 gastrointestinal GI bleeding 51 medulloblastomas 51 intra ocular pressure 51 mitochondrial toxicity 51 uric acid 51 pancreatic cancers 51 BRCA2 mutation 51 Lowering cholesterol 51 atypical femur fractures 51 Thyroid nodules 51 Aβ 51 C reactive protein 51 Alu RNA 51 prescribed statins 51 mutated protein 51 darapladib 51 triglyceride levels 51 hormones estrogen 51 naturally occurring estrogen 51 bezafibrate 51 Stroke Risk 51 hyperhomocysteinemia 51 thyroids 51 antioxidant supplementation 51 ovaries removed 51 congenital brain tumor 51 platelet activation 51 abnormal lipids 51 atrophic gastritis 51 insulin resistance syndrome 51 cognitive decline 51 lowfat diet 51 antidiabetic medication 51 prescribed statin 51 Buyyounouski 51 fructose diet 51 β amyloid 51 histone deacetylases 51 SORL1 51 detect precancerous lesions 51 metabolic syndrome MetS 51 myocardial infarction MI 51 percutaneous interventions 51 paraganglioma 51 mammographic density 51 artherosclerosis 51 cell carcinomas 51 overt hepatic encephalopathy HE 51 APOE ε4 51 intestine colon 51 cancerous 51 salpingo oophorectomy 51 aromatase 51 glucose uptake 51 pharyngeal cancer 51 chromosomal instability 51 lung adenocarcinomas 51 Wegener granulomatosis 51 bronchogenic carcinoma 51 GBM tumors 51 genital herpes infections 51 densest breasts 51 basal cells 51 calcitriol 51 lipofuscin 51 situ LCIS 51 tumor subtypes 51 deep venous thrombosis 51 cardio vascular disease 51 Uterine fibroids 51 seborrheic keratoses 51 sentinel nodes 51 cardiotoxicity 51 NSAID 51 proteinuria 51 benign prostate 51 Folic acid supplements 51 microglial 51 fronto temporal dementia 51 hypoglycemic episodes 51 apoC III 51 enlarged thyroid gland 51 triglycerides 51 silent ischemia 51 lowers LDL cholesterol 51 Duodenal 51 torsade de pointes 51 antihypertensive medications 51 nonseminoma 51 Hyperplasia 51 vestibular schwannomas 51 asymptomatic PAD 51 CLA supplementation 51 visceral fat 51 Epstein Barr virus EBV 51 postmenopausal 51 Avodart 51 oral bisphosphonates 51 HDL2 51 HDL C 51 flavonols 51 Androgen deprivation therapy